Stocks Rally On Economic Data To Begin September

Michael Teague |

Stocks rallied shortly before the closing bell on Tuesday as Wall Street regained some confidence on better than expected economic data, as well as promises from Secretary of State John Kerry that any US intervention against the Syrian regime would be limited, and not metastasize into a “boots on the ground” level of involvement ahead of a planned congressional vote on the matter.

Two economic data points came in well ahead of expectations to kick off the third trimester of the year. The ISM manufacturing index for August jumped from July’s reading of 55.4 to a reading of 55.7, despite economists’ expectations for the number to drop to 53.9, and marking the highest reading since June of 2011.

Meanwhile the Department of Commerce reported better than hoped for construction spending figures in its report for the month of July. While the expectations had been for an increase 0.4 percent on a month-over-month basis, the actual figure came in at an increase of 0.6 percent, indicating a that the US economy is indeed sticking to its path of slow but steady growth.

The Standard & Poor’s 500 index ended the day 0.42 percent higher to a finish at 1,639.76 points, while the Dow Jones Industrial Average ended at 14,833.96 points, a gain of 0.16 percent, and the NASDAQ was up 0.63 percent to 3,612.61 points.



Tech shares helped to lift the NASDAQ higher, with gains on heavy trading for Facebook (FB) , Micron Technology (MU) (one of 2013’s best performing stocks), Yahoo! (YHOO) , and Himax Technologies (HIMX) .

Techs also lifted up the S&P 500, with big gains for Electronic Arts (EA) and semiconductor manufacturer Xilinx (XLNX) . Basic materials stocks also did well, with Freeport-McMoRan Copper & Gold (FCX) , Pioneer Natural Resources ($PXD), and CONSOL Energy (CNX) all ending the day higher.

Defense contractors United Technologies ($UTX) and Boeing (BA) were at the top of the Dow, along with JPMorgan Chase (JPM) also ending the day higher, on heavy volume, despite recent legal woes. Microsoft (MSFT) was a huge drag on the benchmark index, however, after investors evinced skepticism about the struggling tech company’s early-day announcement that it would be purchasing Nokia’s (NOK) devices and handsets unit, along with patents, for some $7.2 billion dollars. Shares had dropped over 4.5 percent ahead by the closing bell, to $31.88, and on nearly three times of the volume of the next most heavily-traded Dow stock of the day, Bank of America (BAC) . For its part, Nokia ended the day 31 percent higher to $5.12 per share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
HIMX Himax Technologies Inc. 9.14 -0.15 -1.56 2,116,405 Trade
FB Facebook Inc. 139.97 -0.37 -0.26 3,861,588 Trade
EA Electronic Arts Inc. 88.48 -0.87 -0.97 333,337 Trade
XLNX Xilinx Inc. 57.91 -0.72 -1.23 248,451 Trade
JPM JP Morgan Chase 86.45 -0.85 -0.97 4,448,404 Trade
UTX United Technologies Corporation 110.52 -1.28 -1.14 335,035 Trade
BAC Bank of America Corporation 22.59 -0.53 -2.29 42,211,441 Trade
NOK Nokia Corporation Sponsored American Depositary Sh 5.46 0.09 1.68 3,244,089 Trade
FCX Freeport-McMoRan Inc. 11.92 -0.89 -6.95 8,863,988 Trade
CNX CONSOL Energy Inc. 15.28 -0.43 -2.74 299,139 Trade
BA Boeing Company (The) 174.35 -1.47 -0.84 417,663 Trade
YHOO Yahoo! Inc. 45.99 -0.41 -0.88 948,323 Trade
MU Micron Technology Inc. 28.65 0.22 0.77 11,948,207 Trade
PXD Pioneer Natural Resources Company 179.14 -1.78 -0.98 167,405 Trade
MSFT Microsoft Corporation 64.52 -0.46 -0.71 3,497,150 Trade
BMKDF BioMark Diagnostics Inc 0.08 0.00 0.00 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…